Clinical Social Workers in Cairo, NY Accepting Medicare
8 Clinical Social Workers found. Showing 1 - 8
 Ms. Janet M Hundertmark, LMSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 905 Greene County Office Bldg, Cairo, NY 12413 Phone: 518-688-9163 |
Sara Kristin Kendall, LCSWR Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 905 Greene Co Office Bldg, Greene Co Mental Health, Cairo, NY 12413 Phone: 518-622-9163 Fax: 518-622-8592 |
Ms. Caitlin H Enright, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 905 Greene County Office Bldg, Cairo, NY 12413 Phone: 518-622-9163 |
Michelle Capuano, LMSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 905 County Office Building, Cairo, NY 12413 Phone: 518-622-9163 |
Kirbie Nelson Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 905 Greene County Office Bldg, Cairo, NY 12413 Phone: 518-622-9163 Fax: 518-622-8592 |
Mrs. Laura J Wood, LCSW-R Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 905 Greene County Office Bldg, Cairo, NY 12413 Phone: 518-622-9163 Fax: 518-622-8592 |
Jessica Lynn Macholdt, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 905 County Office Building, Cairo, NY 12413 Phone: 518-622-9163 |
Stacie J Speed, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 905 Greene Co Office Bldg, Greene Co Mental Health, Cairo, NY 12413 Phone: 518-622-9163 Fax: 518-622-8592 |
News Archive
BioTime to market muscle progenitor cell lines bearing hereditary diseases
BioTime, Inc. today announced that it has elected to market progenitors of muscle stem cells bearing hereditary diseases. BioTime will produce the products from five human embryonic stem (hES) cell lines from Reproductive Genetics Institute (RGI) of Chicago, Illinois.
FDA accepts Genzyme's LEMTRADA sBLA for review
Genzyme, a Sanofi Company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's supplemental Biologics License Application (sBLA) file seeking approval of LEMTRADA (alemtuzumab) for the treatment of relapsing multiple sclerosis (RMS).
Offering more testing choices does not boost colorectal cancer screening rates
Offering patients the choice between home screening or in-office colonoscopy does not increase participation in colorectal cancer screening, according to a new Penn Medicine study.
Imaging data shows brains may have capacity to reverse schizophrenia effects
A team of scientists from across the globe have shown that the brains of patients with schizophrenia have the capacity to reorganize and fight the illness. This is the first time that imaging data has been used to show that our brains may have the ability to reverse the effects of schizophrenia.
› Verified 8 days ago